Where can I find news about BIOCON.NS?

The latest press releases, SEC filings, and earnings call transcripts for Biocon Limited (BIOCON.NS) are listed on this page. Press releases come from the company's investor relations feed; filings come directly from SEC EDGAR.

Where are BIOCON.NS's SEC filings?

Biocon Limited (BIOCON.NS)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

When was BIOCON.NS's last earnings call?

The most recent earnings call transcript for Biocon Limited (BIOCON.NS) is on this page with the full speaker-by-speaker conversation. Older quarter transcripts are also available — click any past quarter pill to load it.

BIOCON.NS

Biocon Limited

NSE·Biotechnology · Healthcare

₹435.20₹2.75−0.63%

Market cap₹594.57B·Market closed·Jul 23 10:00 AM UTC

Press Releases

Shreehas Tambe nombrado CEO y Director General de Biocon Limited con efectos a partir del 1 de abril de 2026
/PRNewswire/ -- Biocon Limited (BSE: 532523) (NSE: BIOCON) anunció hoy el nombramiento de Shreehas Tambe como Director Ejecutivo (Chief Executive Officer) y
prnewswire.comMar 27, 2026 · 6:40 AM
Shreehas Tambe übernimmt zum 1. April 2026 die Rolle des Executive Officer und Managing Director bei Biocon Limited
/PRNewswire/ -- Biocon Limited (BSE: 532523) (NSE: BIOCON) gab heute die Ernennung von Shreehas Tambe zum Chief Executive Officer und Managing Director bekannt
prnewswire.comMar 27, 2026 · 6:20 AM

SEC Filings

No recent filings indexed.

Transcripts

PRO

Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.

Click below to see what's inside, then upgrade to read every transcript for BIOCON.NS and 80,000+ other tickers.

Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.

Frequently Asked Questions About BIOCON.NS

Where can I find news about BIOCON.NS?: The latest press releases, SEC filings, and earnings call transcripts for Biocon Limited (BIOCON.NS) are listed on this page. Press releases come from the company's investor relations feed; filings come directly from SEC EDGAR.
Where are BIOCON.NS's SEC filings?: Biocon Limited (BIOCON.NS)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
When was BIOCON.NS's last earnings call?: The most recent earnings call transcript for Biocon Limited (BIOCON.NS) is on this page with the full speaker-by-speaker conversation. Older quarter transcripts are also available — click any past quarter pill to load it.

Biocon Limited

Frequently Asked Questions About BIOCON.NS

Biocon Limited

Shreehas Tambe nombrado CEO y Director General de Biocon Limited con efectos a partir del 1 de abril de 2026

Shreehas Tambe übernimmt zum 1. April 2026 die Rolle des Executive Officer und Managing Director bei Biocon Limited

Frequently Asked Questions About BIOCON.NS

Shreehas Tambe nombrado CEO y Director General de Biocon Limited con efectos a partir del 1 de abril de 2026

Shreehas Tambe übernimmt zum 1. April 2026 die Rolle des Executive Officer und Managing Director bei Biocon Limited